ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells

Journal of Virology

Volumn 75, Issue 13, 2001, Pages 6143-6153

  Halford, W P ^a   Kemp, C D ^a   Isler, J A ^a   Davido, D J ^a   Schaffer, P A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; DNA BINDING PROTEIN; DOXYCYCLINE; POLYPEPTIDE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; LATENT VIRUS INFECTION; NERVE CELL CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRIGEMINUS GANGLION; VIRUS PLAQUE; VIRUS REACTIVATION;

ADENOVIRIDAE; ANIMALS; CERCOPITHECUS AETHIOPS; DNA-BINDING PROTEINS; DOXORUBICIN; GENETIC VECTORS; HERPES SIMPLEX VIRUS PROTEIN VMW65; HERPESVIRUS 1, HUMAN; IMMEDIATE-EARLY PROTEINS; TRANS-ACTIVATORS; TRIGEMINAL GANGLION; UBIQUITIN-PROTEIN LIGASES; VERO CELLS; VIRAL PROTEINS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0034977956     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.13.6143-6153.2001     Document Type: Article

References (59)

1. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency
2. Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA
3. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells
4. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors
5. High throughput method for creating and screening recombinant adenoviruses
6. Construction of adenoviral vectors
7. Analysis of the promoter sequences of the UL9 gene of herpes simplex virus type 1
8. Isolation and characterization of deletion mutants of herpes simplex virus type l in the gene encoding immediate-early regulatory protein ICP4
9. Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides
10. A viral activator of gene expression functions via the ubiquitin-proteasome pathway
11. Effect of the transcription start region of the herpes simplex virus type I latency-associated transcript promoter on expression of productively infected neurons in vivo
12. RING for destruction?
13. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1
14. Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors
15. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
16. Mechanisms of herpes simplex virus type 1 reactivation
17. ICP0 is required for efficient reactivation of herpes simplex virus type I from neuronal latency
18. Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants to establish wild-type levels of latency in vivo
19. Recurrent herpes simplex in the mouse: Inflammation in the skin and activation of virus in the ganglia following peripheral stimulation
20. Herpes simplex virus type 1 immediate-early protein Vmw110 reactivates latent herpes simplex virus type 2 in an in vitro latency system
21. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0
22. Phosphorylation of the herpes simplex virus type 1 origin binding protein
23. The control of herpes simplex virus type-1 late gene transcription: A 'TATA-box'/cap site region is sufficient for fully efficient regulated activity
24. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis
25. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus
26. Separation of sequences defining basal expression from those conferring alpha gene recognition within the regulatory domains of herpes simplex virus 1 alpha genes
27. Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation
28. The promoter of the latency-associated transcripts of herpes simplex virus type 1 contains a functional cAMP-response element: Role of the latency-associated transcripts and cAMP in reactivation of viral latency
29. 1 into S phase of the cell cycle
30. Genetic analysis of the herpes simplex virus type 1 UL9 gene: Isolation of a LacZ insertion mutant and expression in eukaryotic cells
31. Hexamethylene bisacetamide stimulates herpes simplex virus immediate early gene expression in the absence of trans-induction by Vmw65
32. Two novel adenovirus vector systems permitting regulated protein expression in gene transfer experiments
33. Interaction between the herpes simplex virus type 1 origin-binding and DNA polymerase accessory proteins
34. Heat shock-induced reactivation of herpes simplex virus type 1 in latently infected mouse trigeminal ganglion cells in dissociated culture
35. Herpes simplex virus 1CP0 mutants are hypersensitive to interferon
36. Herpes simplex virus gene expression in neurons: Viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways
37. Repression of viral transcription during herpes simplex virus latency
38. Construction and characterization of herpes simplex virus type 1 mutants with conditional defects in immediate early gene expression
39. Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16
40. Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1
41. Detection of HSV-1 genome in the central nervous system of latently infected mice
42. Herpes simplex viruses and their replication
43. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture
44. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27
45. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency
46. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia
47. Expression of a cellular gene cloned in herpes simplex virus: Rabbit beta-globin is regulated as an early viral gene in infected fibroblasts
48. Relationship between the envelope and the infectivity of herpes simplex virus
49. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia
50. Latent herpes simplex virus in spinal ganglia of mice
51. RNA complementary to a herpesvirus α gene mRNA is prominent in latently infected neurons
52. The transcriptional activation domain of VP16 is required for efficient infection and establishment of latency by HSV-1 in the murine peripheral and central nervous systems
53. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency
54. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression
55. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins
56. Advances in adenoviral vectors: From genetic engineering to their biology
57. Reactivation of latent herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products